GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD – Trademark Portfolio

Entity Type: 99

GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SHYNECOOSP. The owner is based in AUTONOMOUS REGION (ROOM 473).

WORKSHOP 1001, 10TH FLOOR, BUILDING A, GUANGXI YOUTH ENTREPRENEURSHIP AND INNOVATION BASE, NO. 46 KONGGANG AVENUE, XINNING TOWN, FUSUI COUNTY, CHONGZUO CITY,

GUANGXI ZHUANG

AUTONOMOUS REGION (ROOM 473) , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD have?

GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD file in?

GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD's most well-known trademarks?

GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD's registered trademark portfolio includes well-known marks such as SHYNECOOSP. These are among 1 currently registered trademark in the portfolio.

What is GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD's trademark registration success rate?

GUANGXI CHONGZUO MUSHENG TECHNOLOGY CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.